Dynatronics third-quarter fiscal 2010 sales increase 7.9% to $8,235,060

Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fiscal third quarter ended March 31, 2010.

Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.

"Sales of both rehabilitation capital equipment and medical supplies increased over last year's results for the quarter and nine-month periods," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "This is the most significant positive indicator we have seen since recessionary pressures began affecting the economy in the United States in 2008.  We attribute these positive trends to our aggressive marketing efforts and, hopefully, a slight easing of recessionary pressures."

Pre-tax income for the quarter ended March 31, 2010, totaled $160,905, compared to $213,304 for the quarter ended March 31, 2009.  Pre-tax income for the nine months ended March 31, 2010, increased to $612,881 compared to $112,393 for the nine months ended March 31, 2009.

"The 445% increase in pre-tax profits for the nine-month period is reflective of our enhanced marketing efforts and strategic reductions in expenses, and continues a string of six consecutive profitable quarters," Cullimore explained. Pre-tax profits for the current quarter were lower in comparison to the same quarter last year due to the benefit in the prior year of the reversal of an approximately $472,000 accrual for retirement benefits upon cancellation of employment agreements for Cullimore and the company's executive vice president of sales and marketing, Larry Beardall.

Net income for the quarter ended March 31, 2010, was $96,099, or $.01 per share, compared to $141,576, or $.01 per share, for the quarter ended March 31, 2009. Net income increased to $353,022, or $.03 per share, for the nine months ended March 31, 2010, compared to $57,223, or $.00 per share, for the nine months ended March 31, 2009.  

"Our efforts to reduce expenses have been complemented by specific marketing strategies that resulted in the increase in sales reported for the quarter ended March 31, 2010," said Beardall. "With the broad line of products we now offer and a strong sales force that we expect will only grow stronger in the coming year, we believe we are well positioned to develop relationships with large chains of clinics and hospitals, national accounts and group purchasing organizations (GPOs) that buy primarily through negotiated contracts," Beardall added.

SOURCE Dynatronics Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.